CO58 Matching-Adjusted Indirect Comparison (MAIC) of Tepotinib With Capmatinib in Previously Treated Advanced Non-Small Cell Lung Cancer (aNSCLC) With MET Exon 14 (METex14) Skipping
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.137
https://www.valueinhealthjournal.com/article/S1098-3015(22)02341-5/fulltext
Section Title :
Section Order :
10926
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02341-5&doi=10.1016/j.jval.2022.09.137